Sommetrics founder and CEO, Richard Rose, shares why aerSleep II is a significant improvement over CPAPs and how they intend to make inroads in the $6B sleep apnea market.
InflammX CEO, Dr. Brian Levy shares details of a very promising development in the treatment of two of the most common and devastating side effects of diabetes.
Assembly Bio CEO, Dr. John McHutchison, presents the company’s three-tiered strategic approach to curing HBV and the major inflection points that are coming this year and next.
AltaSeal is a non-surgical solution to the multi-billion dollar permanent contraception market and is superior to the current standard of care.
The BrickellBio leadership team has launched some of the most successful drugs on the market today including Cialis, Prozac, Cymbalta, Juvederm, and more.
How a properly designed blood purification device can perform functions that are beyond the reach of drugs and have broad applications for the treatment of pandemic viruses and beyond.
Avior Bio is ready to enter Phase 2 Clinical Trials for its treatment for pruritis, a $1.3 billion market opportunity with a clear unmet need.
AyuVis founder and CEO, Dr. Suchi Acharya will discuss the dire need for their treatment and the rapid progress that’s being made in saving the lives of pre-term babies.
InflammX CEO, Dr. Brian Levy discusses the opportunity to co-invest in the company and help improve the vision of people with Dry AMD and Diabetic Retinopathy.
Join our webinar to hear former HHS Secretary Tommy Thompson and other health experts discuss the growing public health issue of cannabis addiction and what can be done to help those who want to quit.
1460 Broadway
New York, NY 10036
(917) 747-6198
© Copyright 2021 FORCE Family Office